SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
Over the past two years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections, resulting in an unprecedented pandemic of coronavirus disease 2019 (COVID-19). As the virus spreads through the population, ongoing mutations and adaptations are b...
Main Authors: | Hong-Yu Liang, Yuyan Wu, Vicky Yau, Huan-Xin Yin, Scott Lowe, Rachel Bentley, Mubashir Ayaz Ahmed, Wenjing Zhao, Chenyu Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/9/1538 |
Similar Items
-
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
by: Jialing Yin, et al.
Published: (2022-01-01) -
Investigation of SARS-CoV-2 Variants and Their Effect on SARS-CoV-2 Monoclonal Antibodies, Convalescent and Vaccine Plasma by a Novel Web Tool
by: Ayse Arikan, et al.
Published: (2022-11-01) -
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
by: Taichi Kuramochi, et al.
Published: (2022-12-01) -
Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
by: Kun Wen, et al.
Published: (2023-08-01) -
Immune targets to stop future SARS-CoV-2 variants
by: Milena Silva Souza, et al.
Published: (2023-12-01)